VBIO Latest Headlines

Valion Bio expands preferred equity financing through private placements

at www.tipranks.com (Tue, 27-Oct 6:32 AM)

VBIO Jumps as Valion Completes Needle-Free Oral Mucosal Entolimod Formulation

Market Chameleon (Wed, 30-Sep 10:27 AM)

VBIO Highlights Needle-Free Entolimod Milestone, Pointing to a 10–40x Dose Opportunity Versus Injectable Plans

Market Chameleon (Wed, 30-Sep 9:18 AM)

Ukraine Advances Review of Entolimod, Potentially Paving the Way for First National Registration

Market Chameleon (Fri, 14-Aug 11:59 AM)

Valion Bio Sets Timeline for Pivotal U.S. Government-Funded Studies on Entolimod for Lethal Radiation-Induced GI Injury

Market Chameleon (Wed, 12-Aug 10:28 AM)